Drugs - Generic

  1. What Is Amgen’s New Target?

    Amgen's investors are focusing a lot on its cholesterol-busting drug evolocumab; ...
  2. Sun Pharma And Ranbaxy: An Ideal Pharma Marriage?

    The Sun Pharma merger with Ranbaxy will blend the complementary market strengths ...
  3. Dilip Shanghvi's Net Worth: How Did He Get So ...

    Dilip Shanghvi made Sun Pharma a huge global business through smart acquisitions ...
  4. Want To Make Money In Marijuana? Read This First

    "Investing in cannabis" used to mean buying grow-lights for a hydroponic operation. ...
  5. Big Pharma Faces 'Pay For Delay' Lawsuits

    Unless you follow the pharmaceutical and biotech sectors, it’s likely that you’ve ...
  1. What Is Amgen’s New Target?

    Amgen's investors are focusing a lot on its cholesterol-busting drug evolocumab; ...
  2. The Best Way Into Big Pharma? See This ETF (IHE)

    Pharma investing isn't for everyone, but sector-specific ETFs, such as the iShares ...
  3. A Multi-Asset Income ETF For Defensive Investors

    In light of market volatility and worries that stocks are overbought, one product ...
  4. Why There's Far More To Pfizer Than Viagra

    Pfizer, Inc. is one of the world's largest and most profitable pharmaceutical companies, ...
  5. Akorn Scores A Rare Win-Win Acquisition

    Akorn builds value by buying Hi-Tech
  6. Big Pharma Faces 'Pay For Delay' Lawsuits

    Unless you follow the pharmaceutical and biotech sectors, it’s likely that you’ve ...
Trading Center